EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Non‐surgical management vs active treatment in T1a renal cell carcinoma: a population‐based study

Bassam Mazin Hashim, Andreas Karlsson Rosenblad, Per-Olof Lundgren, Sven Lundstam, Börje Ljungberg iD

BJU International · 2026

DOI: 10.1111/bju.70074 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift BJU International, 2026. Verfasst von Bassam Mazin Hashim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, Uppsala University, Uppsala, Sweden, Centre for Clinical Research, Västmanland Hospital, Västerås, Sweden. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Watchful Waiting. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To compare overall and cancer‐specific survival for clinical (c)T1aN0M0 renal cell carcinoma (RCC) in patients treated with non‐surgical management (NSM: surveillance and watchful waiting) or active treatment (surgery and ablative treatments). Patients and methods In this nationwide real‐world population‐based cohort study, data on clinical, demographic, and socioeconomic factors as well as tumour characteristics and cause of death were retrieved from the Renal Cell Carcinoma Database Sweden (RCCBaSe) for 3989 patients diagnosed with cT1aN0M0 RCC, 2011–2020 and treated with either NSM or active treatment. Differences in survival between NSM and active treated patients were analysed using standard and competing‐risks Cox regression models.

Results

In total, 3727 (93.4%) patients underwent active treatments, while 262 patients (6.6%) were treated with NSM. Patients in the NSM group were significantly older and had a higher comorbidity burden. During a median follow‐up time of 4.1 years, all‐cause mortality was significantly higher among the NSM (38.9%) than the actively treated (10.9%) patients ( P < 0.001), as was cancer‐specific mortality (13.0% vs 3.4%, P < 0.001). Larger tumours, older age, male sex, increased comorbidity, being unmarried or widowed, having lower disposable income, and having clear cell or papillary RCC compared with chromophobe RCC were all independently associated with poorer overall and cancer‐specific survival. One of the limitations is that treatment allocation was not randomised.

Conclusion

Non‐surgical management of cT1aN0M0 RCC was associated with poorer survival compared with surgery/ablation and should be offered mainly for patients with limited life expectancy and indolent renal tumours.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsWatchful WaitingHumansMaleFemaleAgedMiddle AgedSwedenNephrectomyAged, 80 and overNeoplasm Staging

Stichwörter der Autor:innen

active surveillanceall‐cause mortalitycancer‐specific mortalitycohort studykidney cancerrenal cell carcinomarenal tumour biopsysocioeconomic factorssurgery

Autor:innen und Institutionen

  • Department of Surgical Sciences, Uppsala University, Uppsala, Sweden, Centre for Clinical Research, Västmanland Hospital, Västerås, Sweden.
  • Regional Cancer Centre Stockholm-Gotland, Region Stockholm, Stockholm, Sweden.
  • Department of Statistics, Uppsala University, Uppsala, Sweden.
  • Division of Clinical Diabetology and Metabolism, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Division of Urology, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.
  • Department of Urology, Karolinska University Hospital, Stockholm, Sweden.

ORCID-Profile: Börje Ljungberg

Zitieren

APA

Hashim, B. M., Rosenblad, A. K., Lundgren, P. O., Lundstam, S., & Ljungberg, B. (2026). Non‐surgical management vs active treatment in T1a renal cell carcinoma: a population‐based study. BJU International. https://doi.org/10.1111/bju.70074

Vancouver

Hashim BM, Rosenblad AK, Lundgren PO, Lundstam S, Ljungberg B. Non‐surgical management vs active treatment in T1a renal cell carcinoma: a population‐based study. BJU International. 2026. doi:10.1111/bju.70074

BibTeX
@article{Hashim2026,
  author = {Hashim, Bassam Mazin and Rosenblad, Andreas Karlsson and Lundgren, Per-Olof and Lundstam, Sven and Ljungberg, Börje},
  title = {Non‐surgical management vs active treatment in T1a renal cell carcinoma: a population‐based study},
  journal = {BJU International},
  year = {2026},
  doi = {10.1111/bju.70074}
}
Kostenlos starten →